Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07411950Not ApplicableCompleted

EuroPainClinicsStudy IX ( EPCS IX )

Role: collaborator

NCT06641921Not ApplicableCompleted

Strategy TO Prevent Decompensated Heart Failure

Role: collaborator

NCT06456047Not Yet Recruiting

Detection of Early Airway Obstruction in Patients with COPD Using RCexp

Role: lead

NCT06391866Recruiting

Neuroinflammation/Oxidative Stress/Cardiac Surgery

Role: collaborator

NCT05827640Completed

Expiratory Time Constant in Mechanically Ventilated Patients

Role: lead

All 5 trials loaded